DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.88 0.03 (3.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.88 3.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.85
Previous Close $0.85
Daily Range $0.84 - $0.90
52-Week Range $0.84 - $2.43
Market Cap $60.8M
P/E Ratio -1.70
Dividend (Yield) $0.00 (0.0%)
Volume 620,368
Average Daily Volume 758,139
Current FY EPS -$0.61

Sector

Healthcare

Industry

Drugs

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary Rss Feed

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Monday Sector Laggards: Precious Metals, Biotechnology Stocks

A Timely Interview With BioTime's CEO And His Chief Commercial Officer

StemCells Inc. Faces Tough Times Ahead

StemCells, Inc.: More Downside Risk Ahead

Time To Sell Advanced Cell Technology And Buy StemCells, Inc.

StemCells Starts Phase II Cervical Spinal Cord Injury Study - Analyst Blog

StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity

StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript

StemCells (STEM) Q2 2014 Results - Earnings Call Webcast

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Sto

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Stock Sale

See More STEM News...

STEM's Top Competitors

STEM $0.88 (3.76%)
Current stock: STEM
AMGN $163.48 (2.53%)
Current stock: AMGN
GILD $102.40 (1.93%)
Current stock: GILD
BIIB $332.89 (2.39%)
Current stock: BIIB